About AQEMIA AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. At the core of our mission is QEMI, our proprietary molecule-invention platform, which uniquely combines cutting-edge
About AQEMIA AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. At the core of our mission is QEMI, our proprietary molecule-invention platform, which uniquely combines cutting-edge
Enter our world. Transform with us. Founded in 2003, BIP has gathered and enhanced the historical experience of consultancy and added two key ingredients: innovation and digitalization. Thanks to this path BIP is now over 6000
About AQEMIA AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. At the core of our mission is QEMI, our proprietary molecule-invention platform, which uniquely combines cutting-edge
About AQEMIA AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. At the core of our mission is QEMI, our proprietary molecule-invention platform, which uniquely combines cutting-edge
About AQEMIA AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. At the core of our mission is QEMI, our proprietary molecule-invention platform, which uniquely combines cutting-edge
About Mirakl: Founded in 2012, Mirakl has been at the forefront of marketplace innovation, empowering every business to compete in the platform economy. Today, Mirakl’s operating system combines an enterprise marketplace solution (Mirakl Platform) that enables
About AQEMIA AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. At the core of our mission is QEMI, our proprietary molecule-invention platform, which uniquely combines cutting-edge
About AQEMIA AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. At the core of our mission is QEMI, our proprietary molecule-invention platform, which uniquely combines cutting-edge
# Modeling LeadBewerbenlocations: Gentilly: Lyontime type: Vollzeitposted on: Heute ausgeschriebentime left to apply: Enddatum: 23. Juni 2026 (Noch 3 Stunden Zeit für Bewerbung)job requisition id: R HybridJob Title: Modeling Lead* Location: Paris or Lyon *About the job *As
Overview Contentsquare is the all-in-one experience intelligence platform designed to be easily used by anyone who cares about digital journeys. With our flexible and scalable platform, organizations quickly get a deep understanding of their customers’ whole
About AQEMIA AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. At the core of our mission is QEMI, our proprietary molecule‑invention platform, which uniquely combines cutting‑edge
About AQEMIA AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. At the core of our mission is QEMI , our proprietary molecule-invention platform, which uniquely combines
Who We Are Artefact is a French consulting and engineering firm specializing in data and AI, and a leader in Europe. Headquartered in Paris, we are now present in 23 countries across all continents, with a
A forward-thinking tech company in Paris is seeking a Senior Data Scientist to lead its Decision Intelligence team. In this role, you will define the data science strategy, enhance predictive models, and support cross-functional stakeholders with
Emerton Data - Strategy Consultant & Data Scientist - Paris Office Join to apply for the Emerton Data - Strategy Consultant & Data Scientist - Paris Office role at Emerton Emerton Data is the entity of
Overview At Agoda, we bridge the world through travel. Our story began in 2005, and today we are part of Booking Holdings (NASDAQ: BKNG) with a diverse team working globally. Agoda’s Marketing team operates at the
About AQEMIA AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. At the core of our mission is QEMI, our proprietary molecule‑invention platform, which uniquely combines cutting‑edge
MARKET RISK STRATS, RISK, VICE PRESIDENT We are currently seeking experienced candidates for the position of Vice President in the Market Risk Strats team within the Risk Division to lead Equities Market risk Strats. The Market
About AQEMIA AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. At the core of our mission is QEMI , our proprietary molecule-invention platform, which uniquely combines